Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001662252-16-000301
Filing Date
2016-12-23
Accepted
2016-12-23 14:05:05
Documents
1
Period of Report
2016-12-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4.html 4  
1 OWNERSHIP DOCUMENT form4.xml 4 10737
  Complete submission text file 0001662252-16-000301.txt   12275
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address
Benz Edward J. JR (Reporting) CIK: 0001691160 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37937 | Film No.: 162068745